Konstantin Konstantinov's Insider Trades & SAST Disclosures
Konstantin Konstantinov's most recent trade in Repligen Corp. was a trade of 1,376 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Konstantin Konstantinov.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,376 | 1,376 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 701 | 1,921 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 1,487 | 1,487 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 686 | 1,220 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 2,498 | 2,498 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 1,298 | 1,298 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Konstantin Konstantinov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 534 | 534 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 87.11 per share. | 22 Feb 2021 | 5,224 | 82,151 (0%) | 0% | 87.1 | 455,039 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 88.50 per share. | 22 Feb 2021 | 474 | 81,677 (0%) | 0% | 88.5 | 41,948 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 11,610 | 11,610 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,144 | 3,144 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,571 | 88,071 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.17 per share. | 17 Feb 2021 | 696 | 87,375 (0%) | 0% | 87.2 | 60,670 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 3,999 | 90,498 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 3,999 | 3,999 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 76.81 per share. | 21 Jan 2021 | 2,226 | 86,500 (0%) | 0% | 76.8 | 170,979 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.43 per share. | 21 Jan 2021 | 1,772 | 88,726 (0%) | 0% | 77.4 | 137,206 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 06 Jan 2021 | 16,547 | 86,499 (0%) | 0% | 75.3 | 1,245,658 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 74.30 per share. | 06 Jan 2021 | 7,471 | 103,046 (0%) | 0% | 74.3 | 555,095 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 73.30 per share. | 06 Jan 2021 | 2,200 | 110,517 (0%) | 0% | 73.3 | 161,260 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 71.63 per share. | 06 Jan 2021 | 626 | 112,717 (0%) | 0% | 71.6 | 44,840 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 60,314 | 157,527 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.28 per share. | 04 Jan 2021 | 44,184 | 113,343 (0%) | 0% | 73.3 | 3,237,804 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 39,196 | 97,213 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 27,942 | 27,942 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 17,260 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 12,261 | 12,261 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 9,675 | 19,352 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.05 per share. | 16 Sep 2020 | 21,351 | 57,373 (0%) | 0% | 14.1 | 299,982 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2020 | 21,351 | 50,461 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 78.88 per share. | 16 Sep 2020 | 8,919 | 36,022 (0%) | 0% | 78.9 | 703,531 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 16,014 | 16,014 | - | - | Restricted Stock Units | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 16,014 | 52,036 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.54 per share. | 11 Sep 2020 | 7,095 | 44,941 (0%) | 0% | 70.5 | 500,481 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.05 per share. | 06 May 2020 | 59,794 | 95,183 (0%) | 0% | 14.1 | 840,106 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2020 | 59,794 | 71,812 | - | - | Stock Option (Right to Buy) | |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 41.19 per share. | 06 May 2020 | 59,794 | 35,389 (0%) | 0% | 41.2 | 2,462,915 | Ordinary Shares |
| Horizon Therapeutics Plc | Irina P. Konstantinovsky | EVP, Chief Human Resources Off | Sale of securities on an exchange or to another person at price $ 34.13 per share. | 20 Apr 2020 | 19,886 | 35,389 (0%) | 0% | 34.1 | 678,685 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges